Zena Therapeutics Inc. — Form D
Zena Therapeutics Inc. of PRINCETON, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-07. The offering totals $500K, of which $500K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-09-07
- Form: D
- Accession: 0001878646-23-000027
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $500K
- Investors: 1
- Date of first sale: 2023-08-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-491564
Issuer
- Name: Zena Therapeutics Inc.
- CIK: 0001992540
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 155 VILLAGE BLVD, PRINCETON, NJ, 08540
- Phone: 848-229-4215
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Eileen Carry | Director | Princeton, NJ |
| Ariane Vasilatis | Director | Princeton, NJ |
| Eileen Carry | Executive Officer | Princeton, NJ |
| Ariane Vasilatis | Executive Officer | Princeton, NJ |
More